
January 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

January 31, 2018 Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma

January 31, 2018 Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical

January 31, 2018 Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma

January 31, 2018 Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical

January 30, 2018 Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical

January 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation

January 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

January 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate

January 26, 2018 Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

January 25, 2018 Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

January 24, 2018 Research and Development Georgia State University, Vaccine, flu, influenza, pharma

January 24, 2018 Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma